⌘K

Home/Filings/4/0001209191-20-035040

4//SEC Filing

Friedman Bart 4

Accession 0001209191-20-035040

CIK 0001636651other

View on SEC.gov Company Profile

Filed

Jun 7, 8:00 PM ET

Accepted

Jun 8, 5:38 PM ET

Size

5.3 KB

Accession

0001209191-20-035040

Insider Transaction Report

Form 4

Period: 2020-06-05

Ovid Therapeutics Inc.OVID

Director

Transactions

Award
Stock Option (Right to Buy)
2020-06-05+13,250→ 13,250 total
Exercise: $5.29Exp: 2030-06-04→ Common Stock (13,250 underlying)

Footnotes (1)

[F1]The option will vest in full on June 5, 2021, subject to the Reporting Person's continuous service through such vesting date.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Ovid Therapeutics Inc.

CIK 0001636651

Entity typeother

Related Parties

1

filerCIK 0001368324

Filing Metadata

Form type: 4
Filed: Jun 7, 8:00 PM ET
Accepted: Jun 8, 5:38 PM ET
Size: 5.3 KB

View on SEC.gov